FDA Adds Several Peptides to Category 2 Bulks List, Restricting Them From Compounding Restore Health Consulting BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step FDA mulls compounding for peptides previously flagged over safety risks BioSpace In 2026, the question "Are peptides legal?" has been answered with a decisive regulatory crackdown. , The FDA has moved beyond general oversight into targeted enforcement. Popular wellness Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy